About Ferring Therapeutics Private Limited
Data last updated:
Ferring Therapeutics Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Ferring B.V.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2011PTC224424. Its GSTIN is 27AABCF8527B1ZU (Maharashtra).
The company has an authorised share capital of ₹300 Cr and a paid-up capital of ₹272.85 Cr. It is led by directors including Anindya Ghosh (Managing Director) and Jens Eric Regelin.
Its last annual general meeting (AGM) was held on 27 November 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at Plot No. K – 28/1 Additional MIDC Anand Nagar Ambernath (E), Thane, Maharashtra, India – 421506.
As per the financials filed for FY 2022, the company reported a revenue of ₹108.96 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹9.69 Cr (net margin 8.9%) and EBITDA of ₹26.8 Cr (EBITDA margin 24.6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 16% over five years.
The company has about 84 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it. The company has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹281.47 Cr; the latest was in March 2019. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Alcedo Pharmachem Private Limited with revenue of ₹89.55 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,143 overdue payments to 144 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ferringtherapeutics.business.site.
Company details
Contact details
Ferring Therapeutics Private Limited's registered office is in Thane, Maharashtra. Its website is ferringtherapeutics.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressPlot No. K – 28/1 Additional MIDC Anand Nagar Ambernath (E), Thane, Maharashtra, India – 421506
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ferring Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ferring Therapeutics Private Limited
FY 2024 filings availableFerring Therapeutics Private Limited reported revenue of ₹108.96 Cr (up 20% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 20% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹108.96 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.6% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ferring Therapeutics Private Limited, buy the company report.
Board of directors of Ferring Therapeutics Private Limited
Ferring Therapeutics has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jens Eric Regelin Also directs: Ferring Laboratories Private Limited | Director | 13 Oct 2020 | 6 Years 0 Months | Current |
| Anindya Ghosh Also directs: Ferring Laboratories Private Limited | Managing Director | 01 Dec 2016 | 9 Years 10 Months | Current |
| Robert Flury | Director | 13 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Ferring Therapeutics Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ferring Therapeutics Private Limitedthis company | ₹108.96 Cr (FY 2022) | ₹9.69 Cr | 8.9% | 20.0% | 84 | Thane, Maharashtra, India |
| Alcedo Pharmachem Private Limited | ₹89.55 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | 263.0% | New Delhi, Delhi, India | |||
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | 6.0% | Andhra Pradesh, India | |||
| Sam Fine O Chem Limited | ₹89.46 Cr (FY 2025) | 22.0% | Rajkot, Gujarat, India | |||
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | -2.0% | Indore, Madhya Pradesh, India | |||
| Evertogen Life Sciences Limited | ₹89.28 Cr (FY 2024) | 51.0% | Hyderabad, Telangana, India | |||
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | 421.0% | Mumbai, Maharashtra, India | |||
| Gnosis Pharmaceuticals Private Limited | ₹88.76 Cr (FY 2024) | 18.0% | New Delhi, Delhi, India | |||
| Ravian Life Science Private Limited | ₹88.41 Cr (FY 2025) | 2.0% | Haridwar, Uttarakhand, India |
To see the full peer comparison of Ferring Therapeutics Private Limited, buy the company report.
Auditor
Ferring Therapeutics Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DELOITTE HASKINS & SELLS LLP | FY 2022 | 117366W |
Shareholding
The shareholding of Ferring Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ferring Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Dec 2022 | 100659035 | The Hongkong and Shanghai Banking Corporation Limited | ₹2 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Ferring Therapeutics Private Limited has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹281.47 Cr; the latest was in March 2019.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹171.94 Cr | Investors: an individual |
| Sep 2014 | Funding round | ₹67.5 Cr | Investors: an individual |
| Dec 2013 | Funding round | ₹27.49 Cr | Investors: Ferring Pharmaceuticals Private Limited , an individual |
| Feb 2013 | Funding round | ₹14.54 Cr | Investors: Ferring Pharmaceuticals Private Limited |
| Dec 2012 | Secondary share transfer | Undisclosed | Buyer: Ferring Pharmaceuticals Private Limited , Ferring Laboratories Limited Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ferring Therapeutics Private Limited has 3 court cases on record: 1 filed by Ferring Therapeutics, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Arbitration matter | Filed against the company by M/S. Ashrae Clean Room Presentation Pvt.Ltd. | Disposed |
| Bombay High Court | Arbitration matter | Filed against the company by M/S. Ashrae Clean Room Presentation | Disposed |
| Bombay High Court | Court case (APPP) | Filed by the company against The State of Maharashtra | Disposed |
To see the full case history of Ferring Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ferring Therapeutics Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,143 overdue payments to 144 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 144)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dealmytime Services Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Plenus Global Logistics Solutions Private Limited | |||
| Tata Aig General Insurance Company Limited |
To see the full MSME payment records of Ferring Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ferring Therapeutics Private Limited has a workforce of 84 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Ferring Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCF8527B1ZU | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ferring Therapeutics Private Limited, buy the company report.
Recent activity
Ferring Therapeutics Private Limited has 13 board changes on record since 2013: 3 appointments and 10 cessations. The latest: Yamini Manohar Shinde ceased to be Director on 07 Jun 2022.
5 earlier events are in the company report.
Frequently asked questions
Ferring Therapeutics is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2011 (15+ years old) and is registered under CIN U74120MH2011PTC224424.
Ferring Therapeutics has 3 current directors:
- Anindya Ghosh - Managing Director
- Jens Eric Regelin - Director
- Robert Flury - Director
The latest financial statements of Ferring Therapeutics on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 27 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ferring Therapeutics is 27AABCF8527B1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ferring Therapeutics is U74120MH2011PTC224424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ferring Therapeutics has 3 court cases on record: 1 filed by the company and 2 filed against it.
Ferring Therapeutics was incorporated on 28 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Ferring Therapeutics has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹281.47 Cr; the latest was in March 2019.
The peers of Ferring Therapeutics by revenue are Alcedo Pharmachem Private Limited, Shrey Nutraceuticals and Herbals Private Limited, Verdant Life Sciences Private Limited, Sam Fine O Chem Limited, Medilux Laboratories Pvt Ltd and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Yamini Manohar Shinde ceased to be Director on 07 Jun 2022. Robert Flury ceased to be Additional Director on 30 May 2022. Robert Flury was appointed as Director on 13 Apr 2022. Ferring Therapeutics has 13 board changes on record in total.
Ferring Therapeutics has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,143 overdue payments to 144 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Ferring Therapeutics can be reached through the website ferringtherapeutics.business.site. Its registered office is in Thane, Maharashtra, India.